US-based therapeutics device company Clarimedix secured an undisclosed amount of funding on Wednesday from the Johnson & Johnson Corporate Office of Science and Technology (COSAT), part of the pharmaceutical conglomerate’s website where innovators submit ideas to Johnson & Johnson operating companies.. Clarimedix focuses its research on disorders associated with blood vessel problems, Alzheimer’s disease among…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
